Recent Quotes (30 days)

You have no recent quotes
chg | %

Critical Outcome Technologies Inc.  

(Public, CVE:COT)   Watch this stock  
Find more results for COT
0.435
-0.020 (-4.40%)
Delayed:   11:45AM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.44 - 0.46
52 week 0.19 - 0.65
Open 0.45
Vol / Avg. 17,100.00/195,548.00
Mkt cap 57.50M
P/E     -
Div/yield     -
EPS -0.03
Shares 139.45M
Beta 0.63
Inst. own     -
Mar 11, 2016
Q3 2016 Critical Outcome Technologies Inc Earnings Release
  

Key stats and ratios

Q1 (Jan '16) 2015
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -66.08% -126.67%
Return on average equity -118.27% -251.35%
Employees 10 -
CDP Score - -

Address

700 Collip Cir Suite 213
LONDON, ON N6G 4X8
Canada
+1-519-8585157 (Phone)
+1-519-8585179 (Fax)

Website links

Description

Critical Outcome Technologies Inc. (COTI) is a Canada-based clinical-stage biopharmaceutical company. The Company uses machine learning to develop targeted therapies. The Company's business is disease-specific drug discovery, optimization and pre-clinical development using a developed series of computer models. Its artificial intelligence platform, CHEMSAS, utilizes a series of predictive computer models to identify compounds that are projected to have a high probability of being developed from disease specific drug discovery through chemical optimization and preclinical testing. The CHEMSAS platform technology is focused on small molecules, and as a drug candidate discovery engine can be applied to any disease. The Company is engaged in developing molecules through the preclinical testing stage as commercial validation of the CHEMSAS platform. COTI-2 is the Company's small molecule activator of misfolded mutant p53 protein.

Officers and directors

John C. Drake Independent Chairman of the Board
Wayne R. Danter M.D. President, Chief Executive Officer, Chief Scientific Officer, Director
Gene Kelly Chief Financial Officer
Douglas S. Alexander Independent Director
Bruno C. Maruzzo Independent Director
Age: 61
Dave Sanderson Independent Director
Alison Silva Independent Director